Clinical Trial: A Multinational Trial of the Efficacy of Albendazole Against Soil-transmitted Nematode Infections in Children
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Multinational Trial of the Efficacy of Albendazole Against Soil-transmitted Nematode Infections in Children
Brief Summary: The three major Soil-Transmitted Helminths (STH), Ascaris lumbricoides, Necator americanus/Ancylostoma duodenal and Trichuris trichiura are among the most prevalent parasites worldwide. The objective of this multicentre international study is to define the efficacy of a single 400 milligram dose of albendazole (ALB) against these three STHs using a standardised protocol. The trial will be undertaken among school age children in seven countries - Brazil, Cameroon, Cambodia, Ethiopia, India, Tanzania (Zanzibar) and Vietnam - each with a different epidemiologic pattern of infection. A trial of this nature is urgently required because in spite of the wide usage of albendazole over the last 3 decades, there is still no key publication reporting the efficacy of the anthelmintic accurately, and to modern conventional standards, that can act as a central reference for the baseline efficacy. The latter is critically important because albendazole is now being used even more widely, as large scale mass treatment campaigns are being implemented in Africa and elsewhere, with the intention of reducing morbidity in children. Such large scale usage of a drug risks resistance developing, but resistance cannot be detected unless benchmark values for baseline efficacy are widely known.
Detailed Summary:
Sponsor: University Ghent
Current Primary Outcome: Efficacy of albendazole [ Time Frame: 14 to 30 days after treatment ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University Ghent
Dates:
Date Received: March 12, 2010
Date Started: January 2009
Date Completion:
Last Updated: July 30, 2011
Last Verified: July 2011
